BSE filing, NSE: RAMCOSYS. Summary written from the filing by ALFA Finder's alert engine.
Ramco Systems Ltd: key numbers
- Share price
- ₹527.10
- Market cap
- ₹1,984 Cr
- Revenue (annual)
- ₹705.1 Cr
- Net profit (annual)
- ₹41.84 Cr
- P/E (TTM)
- 68.1×Sector 22.9×
- Promoter holding
- 55.44%-0.07% QoQ
- FII holding
- 10.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ramco Systems Ltd
All →Ramco Systems Employee Stock Options
Ramco Systems allotted 13,738 equity shares on ESOP exercises under ESOS 2013, 2014 and 2022. The equity share count rose to 3,76,46,385.
Ramco Systems Results Update
Ramco Systems released its Q2 FY27 press release, showing USD 19.20m revenue, USD 2.87m EBITDA and a fact sheet. The filing also includes a consolidated income statement in USD.
Ramco Systems Q2 FY27 Results: Net Profit ₹0.4 Cr, Down 96.8% YoY
Ramco Systems Ltd reported revenue from operations of ₹182 Cr (+3.5% YoY) and net profit of ₹0.4 Cr (-96.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.4 Cr · -96.8% YoY
Ramco Systems Credit Rating
ICRA upgraded the credit rating for Ramco Systems Limited's ₹150.00 Crore bank facilities. This regulatory disclosure provides details of the revised ratings for existing credit lines.
- Value
- ₹150.0 Cr
Ramco Systems Other Announcement
Ramco Systems Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory disclosure under SEBI LODR.
Ramco Systems Board Meeting Date
Ramco Systems will hold a board meeting on October 23, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Other other announcement announcements
All →Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Banaras Beads Other Announcement
Banaras Beads Ltd filed its half-year related-party transaction disclosure under Listing Regulation 23(9). The filing reports routine remuneration and sitting fees to promoters and directors.
Gita Renewable Energy Other Announcement
Gita Renewable Energy intimated a change in its CIN after altering its Objects Clause. The change followed a Special Resolution at its 16th AGM.
Indian Toners & Developers Other Announcement
Indian Toners & Developers has intimated that NSE approved listing of its 5.19 crore equity shares (₹2 face value) on the NSE Mainboard effective October 30, 2026. This is an additional-exchange admission of already-issued BSE-listed shares.
Indian Phosphate Other Announcement
Indian Phosphate filed a Reg 27(2) governance non-applicability certificate for Q1 FY2027. The routine compliance filing carries no transaction or financial impact.